Clinical trial
Evaluation of the Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents: a Multicenter, Double-blind, Randomised, Placebo Controlled, Parallel Group Clinical Investigation
NCT01342601 is registered in ClinicalTrials.gov with Bitop AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents: a Multicenter, Double-blind, Randomised, Placebo Controlled, Parallel Group Clinical Investigation
- Lead sponsor
- Bitop AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- September 30, 2011
- Enrollment
- 72 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
seasonal allergic conjunctivitis, seasonal allergic rhinitis